[Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles].
Martínez-Suárez
J V
JV
Unidad de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid.
Rodríguez-Tudela
J L
JL
D000935:Antifungal Agents / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D002176:Candida albicans / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects; D004261:DNA Replication / Q000187:drug effects; D004271:DNA, Fungal / Q000096:biosynthesis / Q000187:drug effects; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D005658:Fungi / Q000187:drug effects* / Q000235:genetics; D007093:Imidazoles / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D009181:Mycoses / Q000188:drug therapy; D013329:Structure-Activity Relationship; D014230:Triazoles / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use
D000935:Antifungal Agents; D004271:DNA, Fungal; D007093:Imidazoles; D014230:Triazoles